Eagle Pharmaceuticals Inc (EGRX) USD0.001
Sell:$1.50Buy:$1.50
$0.20
(15.38%)
- This stock can be held in a
Stocks and Shares ISA
Fund and Share Account$0.20
(15.38%)$0.20
(15.38%)Company Information
About this company
Eagle Pharmaceuticals, Inc. is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial capabilities. The Company is focused on developing medicines that result in improvements in patients' lives. The Company's commercialized products include vasopressin, PEMFEXY, RYANODEX, BENDEKA, BELRAPZO, TREAKISYM (Japan), and BYFAVO and BARHEMSYS through its wholly owned subsidiary Acacia Pharma Inc. Its oncology and central nervous system (CNS)/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. The Company also has a research and development facility in Cambridge, Massachusetts. The Company is also focused on developing medicines with the potential to become part of the personalized medicine paradigm in cancer care. The Company has office space in Palm Beach Gardens, Florida and Indianapolis, Indiana.
Key people
Key facts
- EPICEGRX
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS2697961082
- Market cap$16.88m
- Employees134
- Shares in issue17.54m
- ExchangeOver The Counter
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.